Greater in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and somatostatin secretory pulses.

Greater in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and somatostatin secretory pulses.

To examine the control of pulsatile insulin secretion by an intrapancreatic pacemaker, samples at minute intervals were taken from the portal vein in dogs in vivo and from an isolated perfused pancreas preparation in vitro. Anesthetized dogs had high amplitude pulsatile insulin secretion which was n...

Bibliografski detalji
Glavni autori:	Matthews, DR, Hermansen, K, Connolly, A, Gray, D, Schmitz, O, Clark, A, Orskov, H, Turner, R
Format:	Journal article
Jezik:	English
Izdano:	1987

Slični predmeti

SOMATOSTATIN AS A POSSIBLE MEDIATOR OF INSULIN AND GLUCAGON PULSATILE SECRETION
od: Frank, M, i dr.
Izdano: (1987)

SOMATOSTATIN INDUCTION OF PULSATILE INSULIN-SECRETION IN TYPE-2 DIABETES-MELLITUS - EFFECT ON INSULIN SENSITIVITY
od: Rice, H, i dr.
Izdano: (1992)

Pulsatile, synchronous basal insulin and glucagon secretion in man.
od: Lang, D, i dr.
Izdano: (1982)

PULSATILE SECRETION OF INSULIN - REPLY
od: Matthews, D, i dr.
Izdano: (1988)

Pulsatile insulin has greater hypoglycemic effect than continuous delivery.
od: Matthews, DR, i dr.
Izdano: (1983)

Control of pulsatile insulin secretion in man.
od: Matthews, DR, i dr.
Izdano: (1983)

Pulsatile insulin has greater hypoglycemic effect than continuous delivery
od: Matthews, DR, i dr.
Izdano: (1983)

Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes.
od: O'Rahilly, S, i dr.
Izdano: (1988)

Fasting glucose concentration has a greater effect than BMI on insulin pulsatility in normal subjects
od: Ahmed, S, i dr.
Izdano: (1997)

Measurement of Pulsatile Insulin Secretion: Rationale and Methodology
od: Marcello C. Laurenti, i dr.
Izdano: (2021-06-01)

GREATER HYPOGLYCEMIC EFFECT WITH PULSED INSULIN THAN WITH STEADILY-INFUSED INSULIN, MEDIATED BY RECEPTOR CHANGES
od: Matthews, D, i dr.
Izdano: (1982)

Greater hypoglycaemic effect with pulsed insulin than with steadily infused insulin, mediated by receptor changes
od: Matthews, DR, i dr.
Izdano: (1982)

LOSS OF REGULAR PULSATILE INSULIN-SECRETION IN ISLET CELL ANTIBODY POSITIVE SUBJECTS WITH NORMAL STIMULATED INSULIN-RESPONSE
od: Bingley, P, i dr.
Izdano: (1989)

Insulin prevents counter-regulatory glucagon secretion by stimulation of somatostatin release
od: Rorsman, P, i dr.
Izdano: (2013)

IMPAIRED PULSATILE INSULIN-SECRETION - CAUSAL DEFECT OR EPIPHENOMENON OF TYPE-2 DIABETES - REPLY
od: Matthews, D, i dr.
Izdano: (1989)

Physiology of insulin secretion: problems of quantity and timing.
od: Matthews, DR, i dr.
Izdano: (1985)

Insulin secretion and the aetiology of non-insulin-dependent diabetes
od: Matthews, D, i dr.
Izdano: (1997)

ASSESSMENT OF INSULIN AND C-PEPTIDE HALF-LIFE IN MAN BY SOMATOSTATIN SUPPRESSION AND DEMONSTRATION THAT INSULIN DELIVERY IN THE BASAL STATE IS AN ON-OFF PHENOMENON
od: Matthews, D, i dr.
Izdano: (1983)

[Insulin secretion in non-insulin-dependent diabetes]
od: Turner, R, i dr.
Izdano: (1991)

Insulin secretion in non-insulin-dependent diabetes
od: Turner, R, i dr.
Izdano: (1991)

The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression.
od: Matthews, DR, i dr.
Izdano: (1985)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
od: Vergari, E, i dr.
Izdano: (2019)

Somatostatin but not insulin is an important paracrine regulator of glucagon secretion in rat A-cells
od: Renstrom, E, i dr.
Izdano: (1997)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
od: Elisa Vergari, i dr.
Izdano: (2019-01-01)

Higher body mass index is associated with irregular and suppressed insulin pulsatility.
od: Hill, N, i dr.
Izdano: (2007)

Pathogenesis of NIDDM--a disease of deficient insulin secretion.
od: Turner, R, i dr.
Izdano: (1988)

Inside the Insulin Secretory Granule
od: Mark Germanos, i dr.
Izdano: (2021-08-01)

Insulin secretion--the ups and downs.
od: Matthews, DR
Izdano: (1987)

Insulin pulsatility after the intravenous glucose bolus
od: Nedeljković-Beleslin Biljana, i dr.
Izdano: (2016-01-01)

ESTIMATION OF INSULIN-SECRETION RATE BY DECONVOLUTION ANALYSIS OF C-PEPTIDE AND OF INSULIN GIVES CONSISTENT RESULTS
od: Rudenski, A, i dr.
Izdano: (1986)

Physiological implications of pulsatile hormone secretion.
od: Matthews, DR
Izdano: (1991)

Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin
od: Charles eBrunicardi, i dr.
Izdano: (2014-06-01)

Isolation and Proteomics of the Insulin Secretory Granule
od: Nicholas Norris, i dr.
Izdano: (2021-04-01)

Implantable batteryless device for on-demand and pulsatile insulin administration
od: Seung Ho Lee, i dr.
Izdano: (2017-04-01)

Leucine is a better priming agent than arginine for insulin secretion in gliclazide treated NIDDM
od: Matthews, DR, i dr.
Izdano: (1997)

Allelic variation at the INS VNTR locus is associated with changes in the pattern of pulsatile insulin release
od: Ahmed, S, i dr.
Izdano: (1998)

Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.
od: Mullis, P, i dr.
Izdano: (1992)

SOMATOSTATIN INHIBITION OF INSULIN-INDUCED GLUCOSE-UPTAKE IN SKELETAL-MUSCLE
od: Williams, J, i dr.
Izdano: (1986)

Diabetes - when insulin is trapped in the secretory granule?
od: Rorsman, P
Izdano: (2008)

Secretion of parathyroid hormone may be coupled to insulin secretion in humans
od: Marie Reeberg Sass, i dr.
Izdano: (2020-08-01)